Advertisement

Topics

Sanofi to sell generics unit for 1.9 billion Euros

05:56 EDT 17 Apr 2018 | PharmaTimes

Global investment group Advent International says it has entered into exclusive negotiations to buy Sanofi’s generics arm Zentiva for 1.9 billion Euros ($2.4 billion).

Original Article: Sanofi to sell generics unit for 1.9 billion Euros

NEXT ARTICLE

More From BioPortfolio on "Sanofi to sell generics unit for 1.9 billion Euros"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Sanofi-Aventis
Sanofi-Aventis is a global pharmaceutical company with annual sales of $40,871m, placing it the second highest in the world. Although Sanofi-Aventis products are for a a very wide range of health problems, their major products are those for diabetes, o...